Despite benefits, blockchain adoption is slow in life sciences, says reportWidespread adoption of blockchain could add $3 billion-worth of value to life sciences companies by 2025, but adoption Share XDespite benefits, blockchain adoption is slow in life sciences, says reporthttps://pharmaphorum.com/news/despite-benefits-blockchain-adoption-is-slow-in-life-sciences-says-report/
Oviva raises $21m for digital tool to help reverse diabetesSwiss digital therapy specialist Oviva has raised $21 million in second-round financing to help expand the use of Share XOviva raises $21m for digital tool to help reverse diabeteshttps://pharmaphorum.com/news/oviva-raises-21m-for-digital-tool-to-help-reverse-diabetes/
Digital therapeutics and their impact on societyIn the 20th century, research, technology and new novel treatments have enabled us to increase the average lifespan Share XDigital therapeutics and their impact on societyhttps://pharmaphorum.com/partner-content/digital-therapeutics-and-their-impact-on-society/
NICE backs Medtronic’s AF monitor in post-stroke patientsEngland’s NHS could prevent hundreds of strokes of unknown cause with a new implantable monitor that transmits data Share XNICE backs Medtronic’s AF monitor in post-stroke patientshttps://pharmaphorum.com/news/nice-backs-medtronics-af-monitor-in-post-stroke-patients/
Digital therapeutics grow upBack in January, pharmaphorum caught up with the Syneos Health team to discuss their experience and insights into Share XDigital therapeutics grow uphttps://deep-dive.pharmaphorum.com/magazine/patient-engagement/digital-therapeutics-grow-up-patient-syneos/
AI specialist Exscientia signs drug discovery tie-up with BayerUK artificial intelligence company Exscientia has added another big pharma company to its partner roster, with Bayer seeking Share XAI specialist Exscientia signs drug discovery tie-up with Bayerhttps://pharmaphorum.com/news/ai-specialist-exscientia-signs-drug-discovery-tie-up-with-bayer/
Preparing for the digital journeyFresh off his appearance at this year’s Frontiers Health conference, we sat down with Sandoz’s head of digital Share XPreparing for the digital journeyhttps://deep-dive.pharmaphorum.com/magazine/patient-engagement/preparing-for-the-digital-journey-sandoz-patients-andre-heeg/
Designing digital solutions that drive adoptionIf any digital patient solution is to have an impact, adoption by its intended end users is critical. Share XDesigning digital solutions that drive adoptionhttps://deep-dive.pharmaphorum.com/magazine/patient-engagement/designing-digital-solutions-that-drive-adoption-s3-patients/
Lilly doubles down on Dexcom tech for connected insulin devicesTwo years ago, Eli Lilly started working with Dexcom to integrate continuous glucose monitoring (CGM) into its insulin Share XLilly doubles down on Dexcom tech for connected insulin deviceshttps://pharmaphorum.com/news/lilly-doubles-down-on-dexcom-tech-for-connected-insulin-devices/
